Login | Signup

UK Games Charts | 9th May 2011

Author:
Jonathan Lester
Category:
News
Tags:
Games news, Mortal Kombat, Portal 2, UK Games Charts, Zumba Fitness
Discuss:
Portal 2

UK Games Charts | 9th May 2011

Wow, when it comes to us gamers, it seems that our drive for physical perfection is more powerful than our lust to expand our minds. Zumba Fitness, the multiplatform aerobic suite, reigns supreme once again thanks to PS3 sales pushing it back onto the top of the chart. It's unseated the reigning champion, Portal 2, which now resides in a worthy second place. Wii Fit Plus hasn't budged an inch: demonstrating our commitment to treating our bodies like the temples they are. And yet somehow I'm still a complete pie? Weird.

Michael Jackson: The Experience has moonwalked into the charts at number ten, but otherwise, the rest of the list contains the old familiar faces we've grown accustomed to over the last few weeks. Travellers Tales are still enjoying strong sales of Lego Star Wars III, and Operation: Flashpoint has sniped itself another week in the limelight. Why not check out our 7/10 review?

There's still no hint of a 3DS exclusive in the top ten - and even Miyamoto's pet submarine project Steel Diver is nowhere in the top forty.

Elsewhere in the charts, this week's new releases haven't enjoyed much in the way of success. The Last Templar has completely failed to chart - although the recently-released PS3 version of Sniper: Ghost Warrior has scored a headshot on number fifteen. Arguably because of its name.

All Format Top 10 – Week ending 7th May (previous chart position in parentheses)

  1. Zumba Fitness (+2)
  2. Portal 2 (-1)
  3. Mortal Kombat (-1)
  4. Call of Duty: Black Ops (+1)
  5. Lego Star Wars III: The Clone Wars (+1)
  6. FIFA 11 (+1)
  7. Operation Flashpoint: Red River (-3)
  8. Wii Fit Plus (-)
  9. Pokemon Black (+3)
  10. Michael Jackson: The Experience (new)
Add a comment0 comments

Email Address:

You don't need an account to comment. Just enter your email address. We'll keep it private.